Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
234 Leser
Artikel bewerten:
(0)

FDA Hosts Middle East and North Africa Food Safety Experts / Conference in Cairo to exchange information on regulatory systems

SILVER SPRING, Md., Sept. 16 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration is hosting a food safety conference for regulators from countries throughout the Middle East and North Africa.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO)

The conference, to be held in Cairo Sept. 20-22, will familiarize regulators with the food safety systems in the United States and the Middle East and North Africa region. U.S. and regional food safety system, highlight fundamentals of food systems rooted in regulatory science, and cover such topics as company registration, inspection, surveillance and risk assessment. It will focus on promoting dialogue among food regulators and include presentations from participating governments. Egypt-based international food producers will also share with the regulators their experience with using regional supply chain management for food safety in production. After the conference, U.S. experts will participate in a workshop held by the American Chamber of Commerce in Egypt.

More than 20 countries have been invited to the event sponsored by the FDA Middle East and North Africa (MENA) Regional Office, which currently operates out of the United States but will formally establish a presence in the region in 2011.

"We are very excited about this conference, the information sharing that will be an outgrowth of this event, and the forging of relationships with regulators from this important region," said Commissioner of Food and Drugs Margaret Hamburg, M.D. "Through venues such as this and by expanding our presence in the region, we can begin the process of understanding other systems, harmonizing standards, and sharing scientific data and emerging technologies, which will ultimately benefit the global food supply."

"This region has very vibrant economies and products that are sought after around the world," said Matthew Tueller, deputy chief of mission at the U.S. embassy in Cairo.

The FDA will send scientists and regulators from its Office of Regulatory Affairs (inspectorate), its Center for Food Safety and Applied Nutrition, its Center for Veterinary Medicine, and its Office of International Programs. Other U.S. government organizations participating include the Centers for Disease Control and Prevention and the U.S. Department of Agriculture. A World Health Organization expert will also be presenting at the conference.

Officials from selected countries will share their successes and challenges in establishing regulations for food safety and managing inspections and surveillance within their jurisdiction.

"We are global citizens in a global economy with a shared responsibility to help ensure that the foods we eat and feed our families have undergone the most rigorous of scientific reviews and inspection. We are eager to collaborate with our counterparts to help protect and promote public health, not only in the United States but around the world," said Murray Lumpkin, M.D., the FDA's deputy commissioner for international programs. "This is a major step toward greater engagement with our Middle East and North Africa counterparts, the beginning of what we hope will be long-standing cooperation."

For more information:

FDA Office of International Programs http://www.fda.gov/InternationalPrograms/default.htm

U.S. Media Inquiries: Michael Herndon, 301-796-4673, michael.herndon@fda.hhs.gov;

Layla Batarseh, 301-385-4196, layla.batarseh@fda.hhs.gov

International Media: Adam Lenart, 011-20-183-414-330, lenertaj@state.gov; Latifa Taylor, 011-20-122-360-207, taylorlb@state.gov

Consumer Inquiries: 888-INFO-FDA

Photo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO
PRN Photo Desk, photodesk@prnewswire.com
http://photos.prnewswire.com/prnh/20090824/FDALOGO

U.S. Food and Drug Administration

CONTACT: Michael Herndon, +1-301-796-4673, michael.herndon@fda.hhs.gov,
Layla Batarseh, +1-301-385-4196, layla.batarseh@fda.hhs.gov, both of the U.S.
Food and Drug Administration; International Media: Adam Lenart,
+011-20-183-414-330, lenertaj@state.gov, or Latifa Taylor,
+011-20-122-360-207, taylorlb@state.gov, both for the U.S. Food and Drug
Administration

Web Site: http://www.fda.gov/

© 2010 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.